Technology
In Sinoveda, we recognize numerous bodily functions are affected in a disease process. Therefore, the treatment of a disease requires multiple ingredients.
Using the multiple ingredient/multiple target approach, we have invented a patent pending drug development technology, PPT®, a physiologically based pharmacokinetic/pharmacodynamic model, to identify active ingredients and their potential interactions in complex mixtures.
We use this technology to simultaneously develop standardized nutraceuticals and pharmaceuticals.
PPT® enables us to develop an unlimited variety of products using this multiple ingredient and multiple target (MIMT™) approach.
